Abstract: Diabetic kidney disease(DKD)is the main microvascular complication of diabetes mellitus and a common cause of end stage renal disease.Ferroptosis is involved in the pathogenesis of DKD,therefore drugs targeting iron death may affect the progression of DKD.This article reviews the research progress of inhibiting ferroptosis in the treatment of DKD.